HR Generalist at Legend Biotech

Ghent, Flanders, Belgium

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Human ResourcesIndustries

Requirements

Bachelor’s or Master’s degree
3–5 years of experience in a broad HR role
Fluent in Dutch and English
Proactive, hands-on and service-oriented mindset
Analytical mindset
Strong organizational skills
Strong communication skills—both verbal and written
Attention to detail and accuracy
Ability to handle sensitive information with discretion
Collaborative and flexible team player
Proficiency in Microsoft Office
Experience with HRIS systems is a plus
Experience with internal communications and reporting is a plus

Responsibilities

Provide coordination and administrative support across HR programs such as HR Business Partnering initiatives, talent development, performance management, employee engagement
Keep our HR intranet up to date and contribute to internal communications, presentations, and newsletters
Collect, analyse and report HR data to support informed decision-making and compliance
Coordinate and track progress on HR projects, ensuring smooth execution
Support cost control processes, including purchase order (PO) management
Assist with employee relations activities, such as preparing documentation for Works Council meetings
Help HR Business Partners respond to employee queries on HR related topics, policies and procedures
Support diverse HR initiatives and projects, building on your skills and interests

Skills

HR Business Partnering

Talent Development

Performance Management

Employee Engagement

HR Data Analysis

Employee Relations

HR Policies

Project Coordination

Internal Communications

Cost Control

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free